The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure

Pathology International

Volumn 62, Issue 10, 2012, Pages 665-674

  Guo, Guoning ^a   Cao, Dayan ^b,c   Xu, Huan ^b,c   Ruan, Zhihua ^d   Fei, Lei ^b   Xie, Zhunyi ^b   Wu, Yuzhang ^b   Chen, Yongwen ^b  

^a SOUTHWEST HOSPITAL   (China)

^b The 72 Unit of 69010 Army   (China)

^c Undergraduate Administration Office   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

B7 H3; B7 H4; FGL2; HBV related acute on chronic liver failure; Immunohistochemistry

Indexed keywords

CD31 ANTIGEN; CD68 ANTIGEN; CYTOKERATIN 18; MEMBRANE PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROTEIN B7 H3; UNCLASSIFIED DRUG; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; AGED; ARTICLE; BILE DUCT INJURY; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIVER BIOPSY; LIVER NECROSIS; MACROPHAGE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; AGED; ANTIGENS, CD274; B7 ANTIGENS; BILE DUCTS; BIOLOGICAL MARKERS; BIOPSY; DISEASE PROGRESSION; END STAGE LIVER DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FAILURE, ACUTE; MACROPHAGES; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; T-LYMPHOCYTES; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84866770417     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02856.x     Document Type: Article

References (40)

1. Marsden PA, Ning Q, Fung LS etal. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003; 112: 58-66.
2. Sarin SK, Kumar A, Almeida JA etal. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-82.
3. Liu Q, Liu Z, Wang T etal. Characteristics of acute and sub-acute liver failure in China: Nomination, classification and interval. J Gastroenterol Hepatol 2007; 22: 2101-6.
4. Liu M, Chan CW, McGilvray I etal. Fulminant viral hepatitis: Molecular and cellular basis, and clinical implications. Expert Rev Mol Med 2001; 3: 1-19.
5. Chapoval AI, Ni J, Lau JS etal. B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001; 2: 269-74.
6. Prasad DV, Nguyen T, Li Z etal. Murine B7-H3 is a negative regulator of T cells. J Immunol 2004; 173: 2500-6.
7. Zang X, Thompson RH, Al-Ahmadie HA etal. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 2007; 104: 19458-63.
8. Stanciu LA, Bellettato CM, Laza-Stanca V etal. Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis 2006; 193: 404-12.
9. Tran CN, Thacker SG, Louie DM etal. Interactions of T cells with fibroblast-like synoviocytes: Role of the B7 family costimulatory ligand B7-H3. J Immunol 2008; 180: 2989-98.
10. Suh WK, Wang SX, Jheon AH etal. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci USA 2004; 101: 12969-73.
11. Steinberger P, Majdic O, Derdak SV etal. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 2004; 172: 2352-9.
12. Hashiguchi M, Kobori H, Ritprajak P etal. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci USA 2008; 105: 10495-500.
13. Sun X, Vale M, Leung E etal. Mouse B7-H3 induces antitumor immunity. Gene Ther 2003; 10: 1728-34.
14. + cytolytic T cells. J Immunol 2004; 173: 5445-50.
15. Ma L, Luo L, Qiao H etal. Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy. J Hepatol 2007; 46: 98-106.
16. Wang L, Fraser CC, Kikly K etal. B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol 2005; 35: 428-38.
17. Suh WK, Gajewska BU, Okada H etal. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 2003; 4: 899-906.
18. Ling V, Wu PW, Spaulding V etal. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: Divergent history of functional redundancy and exon loss. Genomics 2003; 82: 365-77.
19. Papenfuss TL, Powell ND, McClain MA etal. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol 2011; 186: 3346-55.
20. Fukushima A, Sumi T, Fukuda K etal. B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 2007; 113: 52-7.
21. Sica GL, Choi IH, Zhu G etal. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003; 18: 849-61.
22. Prasad DV, Richards S, Mai XM etal. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003; 18: 863-73.
23. Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 2009; 229: 145-51.
24. Hansen JD, Du Pasquier L, Lefranc MP etal. The B7 family of immunoregulatory receptors: A comparative and evolutionary perspective. Mol Immunol 2009; 46: 457-72.
25. Suh WK, Wang S, Duncan GS etal. Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol Cell Biol 2006; 26: 6403-11.
26. Zhu G, Augustine MM, Azuma T etal. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. Blood 2009; 113: 1759-67.
27. Luan Y, Ju J, Luo L etal. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection. J Viral Hepat 2012; 19: 23-31.
28. Xie Z, Chen Y, Zhao S etal. Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunol Invest 2009; 38: 624-38.
29. Wasmuth HE, Kunz D, Yagmur E etal. Patients with acute on chronic liver failure display 'sepsis-like' immune paralysis. J Hepatol 2005; 42: 195-201.
30. Li H, Wang C, Guo G etal. The characteristic expression of B7-associated proteins in Langerhans cell sarcoma. Acta Histochem 2012; 114: 733-43.
31. Dong H, Zhu G, Tamada K etal. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 2001; 5: 1365-9.
32. Tseng SY, Otsuji M, Gorski K etal. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001; 193: 839-46.
33. Peng G, Li S, Wu W etal. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008; 45: 963-70.
34. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-92.
35. Sarin SK, Kumar A, Almeida JA etal. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-82.
36. Zhai S, Zhang L, Dang S etal. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol 2011; 24: 303-10.
37. Chen M, Hu P, Peng H etal. Enhanced Peripheral γδT Cells Cytotoxicity Potential in Patients with HBV-Associated Acute-On-Chronic Liver Failure Might Contribute to the Disease Progression. J Clin Immunol 2012; 32: 877-85.
38. Zou Z, Li B, Xu D etal. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol 2009; 43: 182-90.
39. Song H, Park G, Kim YS etal. B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation. Cancer Lett 2008; 266: 227-37.
40. Li C, Fung LS, Crow A etal. Monoclonal anti-prothrombinase (3D4.3) prevents mortality from murine hepatitis virus infection (MHV-3). J Exp Med 1992; 176: 689-97.